fig1

Figure 1. Incidence of BCRL in included studies from 2017-2024 reporting incidence of BCRL for breast reconstruction. § Significantly reduced (↓) incidence of BCRL compared to other selected groups with a higher incidence of BCRL (↑); ‡ Significantly reduced incidence of BCRL for patients who had ALND and chemotherapy; † Full text not available. Data are based on the abstract. BCRL: breast cancer-related lymphedema; ALND: axillary lymph node dissection; LD: latissimus dorsi; DIEP: deep inferior epigastric perforator; OR: Odds Ratio.